Research and Markets: Asthma – Pipeline Review, H2 2013 Reviews Key … – Fort Mills Times

Research and Markets: Asthma – Pipeline Review, H2 2013 Reviews Key
Fort Mills Times
Global Markets Direct's, 'Asthma – Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Asthma, complete with latest updates, and special features

View full post on asthma – Google News

There’s More To Asthma Than Meets The Air – Daily Markets – Daily Markets (press release)

There's More To Asthma Than Meets The Air – Daily Markets
Daily Markets (press release)
WASHINGTON, May 7, 2013 /PRNewswire-USNewswire/ — There is still no cure for asthma, so for 22 million people in the U.S., this chronic disease continues to be a daily burden no matter where they live. But it's not just air pollution they should be

and more »

View full post on asthma – Google News

Asthma And Allergy Foundation Of America Challenges Patients And Caregivers … – Daily Markets (press release)

Asthma And Allergy Foundation Of America Challenges Patients And Caregivers
Daily Markets (press release)
WASHINGTON, Jan 24, 2013 /PRNewswire/ — The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory announced today the launch of Get Smart About Asthma, a comprehensive online asthma management resource that takes a unique

and more »

View full post on asthma – Google News

Research and Markets: Global Asthma Drug Pipeline Capsule – 2012 Update – The Herald | HeraldOnline.com

Research and Markets: Global Asthma Drug Pipeline Capsule – 2012 Update
The Herald | HeraldOnline.com
Fore Pharma's latest report "Global Asthma Drug Pipeline Capsule – 2012 Update" provides most up-to-date information on key Research and Development activities (R&D) in the global Asthma market. It covers active Asthma pipeline molecules in various

and more »

View full post on asthma – Google News

Global Markets for Asthma, COPD Drugs to Hit $47 Billion in 2017 – news Stories


AARP News

Global Markets for Asthma, COPD Drugs to Hit $47 Billion in 2017
news Stories
A new market research report projects growth for the global asthma and chronic obstructive pulmonary disease prescription drug market. The report, published by RnRMarketResearch.com, valued the market at $34.9 billion in 2011 and projects it will reach
Global Markets for Asthma & COPD Drugs to hit $47 Billion in 2017MarketWatch (press release)
Meet held to discuss respiratory diseasesThe Hindu

all 14 news articles »

View full post on asthma – Google News

Research and Markets: Asthma – Pipeline Review, H1 2012 – Business Wire (press release)

Research and Markets: Asthma – Pipeline Review, H1 2012
Business Wire (press release)
Dublin – Research and Markets (http://www.researchandmarkets.com/research/11929672/asthma_pipeline) has announced the addition of Global Markets Direct's new report "Asthma – Pipeline Review, H1 2012" to their offering. Global Markets Direct's, 'Asthma

and more »

View full post on asthma – Google News

Study: Asthma, COPD markets to see revenue growth, innovation – Drug Store News

Study: Asthma, COPD markets to see revenue growth, innovation
Drug Store News
Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan. More than 40 million Americans were diagnosed with asthma or COPD in 2009,
Asthma and COPD Therapies: World Market 2011-2021PR Newswire (press release)
Asthma and COPD Therapies: World Market 2011-2021Sacramento Bee

all 7 news articles »

View full post on asthma – Google News